Cargando…
Structure-based drug repositioning over the human TMPRSS2 protease domain: search for chemical probes able to repress SARS-CoV-2 Spike protein cleavages
In December 2019, a new coronavirus was identified in the Hubei province of central china and named SARS-CoV-2. This new virus induces COVID-19, a severe respiratory disease with high death rate. A putative target to interfere with the virus is the host transmembrane serine protease family member II...
Autores principales: | Singh, Natesh, Decroly, Etienne, Khatib, Abdel-Majid, Villoutreix, Bruno O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384984/ https://www.ncbi.nlm.nih.gov/pubmed/32730844 http://dx.doi.org/10.1016/j.ejps.2020.105495 |
Ejemplares similares
-
Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2
por: Reinke, Lennart Michel, et al.
Publicado: (2017) -
Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease
por: Stevaert, Annelies, et al.
Publicado: (2022) -
In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2–Spike RBD Interface
por: Villoutreix, Bruno O., et al.
Publicado: (2021) -
Improving Soluble Expression of SARS-CoV-2 Spike Priming Protease TMPRSS2 with an Artificial Fusing Protein
por: Ye, Xiao, et al.
Publicado: (2023) -
Virtual screening web servers: designing chemical probes and drug candidates in the cyberspace
por: Singh, Natesh, et al.
Publicado: (2020)